Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from poLight ASA ( (DE:3OL0) ).
poLight ASA has secured a follow-on purchase order valued at NOK 2.6 million from a leading photonics manufacturer for their TLens® technology, which will be used in the Miniature Two-Photon Imaging System developed by the Kavli Institute for Systems Neuroscience. This collaboration highlights the growing interest in tunable optics for advanced neurological research, particularly in exploring conditions like Alzheimer’s and dementia, and underscores poLight’s role in providing critical components for cutting-edge imaging systems.
More about poLight ASA
poLight ASA, listed on the Oslo Stock Exchange, specializes in patented tunable optics technology. Their flagship product, TLens®, mimics the human eye’s autofocus capabilities and is utilized in various devices such as smartphones, wearables, and medical equipment. The company is headquartered in Tønsberg, Norway, with a global presence including employees in countries like Finland, France, and the US.
Average Trading Volume: 316,231
Current Market Cap: NOK1.14B
For an in-depth examination of 3OL0 stock, go to TipRanks’ Overview page.